🧬 Article Summary
A recent study revealed serious harms resulting from the use of a common drug combination in anti-aging experiments known as dasatinib+quercetin (D+Q). This combination caused damage to the myelin sheath in the brains of mice, which is the protective covering of nerve fibers and is responsible for transmitting electrical signals efficiently. The experiment showed that the damage was more severe in young mice compared with older ones, raising major concerns about the safety of using this treatment in longevity research and its unofficial applications.
🧠 The Effect of the D+Q Combination on Brain Health
The dasatinib+quercetin combination is considered one of the important treatments in anti-aging research, as it is believed to help remove senescent cells that contribute to inflammation and age-related diseases. Nevertheless, this combination underwent new scrutiny that revealed unexpected consequences related to brain health, especially the myelin layer.
Myelin is a protective layer surrounding the nerves, facilitating the transmission of electrical signals between the brain and the body. Damage to this layer leads to multiple problems, including:
- Numbness and tingling
- Difficulty moving
- Decline in memory and cognitive functions
Damaged myelin is also associated with chronic neurological diseases such as Multiple Sclerosis.
🌱 The Study and Experiments on Mice
The experiment was conducted on two groups of mice, including young mice (aged 6 to 9 months) and older mice (aged 22 months). Their brains were examined after receiving the D+Q combination, in addition to studying cells of a special type of nerve cells called oligodendrocytes, which are responsible for producing and maintaining myelin.
The result was extremely concerning, as there was severe loss in the myelin layer, with clear deterioration in an important brain region called the corpus callosum, which is the channel that connects the two hemispheres of the brain and supports multiple vital functions.
🧩 “Chemo Brain” and the Similarity to Chemotherapy-Induced Brain Damage
The deterioration of the corpus callosum in mice reflects a type of damage sometimes seen in patients undergoing chemotherapy, known as “chemo brain.” This condition includes disturbances in memory, concentration, and thinking. In other words, anti-aging drugs may cause similar effects, which raises new concern about the safety of their use in longevity-improvement trials.
🧪 How D+Q Affects oligodendrocytes Cells
Despite the damage that occurred, oligodendrocytes did not die. On the contrary, the cells regressed to a state similar to a youthful or progenitor cellular model, which is a less functional stage. This suggests that the drugs can:
- Negatively affect cellular metabolism
- Limit the energy needed for cell functions
- Push cells to simplify their structure and revert to a progenitor state
This abnormal regression is similar to what is observed in cells from patients with multiple sclerosis.
🧬 New Discoveries About the Mechanism of Multiple Sclerosis
The findings suggest that myelin-producing cells in multiple sclerosis may be subjected to stress that drives them back to a less mature state rather than causing direct death. This discovery carries a glimmer of hope that these cells may be repairable and rehabilitated instead of being completely lost.
Research is currently working to investigate the ways in which these cells can be stimulated to regain their function and their ability to repair myelin damage.
🧠 The Future Opportunity to Repair the Brain
If scientists can stimulate these cells to return to a mature functional pattern, this may open the door to new treatments for diseases such as multiple sclerosis and other brain injuries associated with aging or drugs.
However, it should be noted that animal experiments showed that D+Q treatment carries significant risks before it is approved as a safe therapy, especially with regard to brain functions.
🩺 Recommendations and Guidance for Researchers and Users
This study highlights the importance of carefully examining the effects of unconventional drugs, especially those used outside medical supervision, such as some anti-aging therapies.
The findings warn against using the D+Q combination without close medical follow-up, as it can cause severe neurological problems, especially in young people, which runs counter to the intended benefits in longevity and health improvement.
🌟 Conclusion
While the dasatinib and quercetin combination shows promising potential in clearing senescent cells and promoting health beyond age-related diseases, the emergence of clear brain damage—especially to the myelin layer—raises an important warning about its safety and effectiveness.
These findings call for more in-depth studies to understand the neurological mechanisms of these drugs, ensure that the brain is not exposed to the risk of damage, and continue researching how damaged cells can regain their functions in order to develop safe and effective treatments for chronic brain disorders.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
